Point72 Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-605,243
Closed -$132M 2813
2023
Q2
$132M Buy
605,243
+209,935
+53% +$46.8M 0.39% 50
2023
Q1
$86.6M Buy
395,308
+160,883
+69% +$34.9M 0.27% 85
2022
Q4
$48.8M Sell
234,425
-163,436
-41% -$35.9M 0.17% 159
2022
Q3
$86.9M Buy
397,861
+282,613
+245% +$64.3M 0.35% 60
2022
Q2
$24.2M Buy
115,248
+79,973
+227% +$17M 0.1% 271
2022
Q1
$8.55M Buy
+35,275
New +$8.53M 0.03% 555
2021
Q3
Sell
-82,344
Closed -$20.3M 1212
2021
Q2
$20.3M Buy
+82,344
New +$17.3M 0.09% 284
2020
Q3
Sell
-9,999
Closed -$1.92M 1074
2020
Q2
$1.92M Sell
9,999
-11,338
-53% -$1.86M 0.01% 598
2020
Q1
$3.14M Buy
+21,337
New +$3.4M 0.03% 445
2019
Q4
Sell
-2,923
Closed -$395K 1209
2019
Q3
$395K Buy
+2,923
New +$383K ﹤0.01% 813
2019
Q1
Sell
-40,200
Closed -$4.58M 1200
2018
Q4
$4.58M Buy
40,200
+33,600
+509% +$3.6M 0.02% 575
2018
Q3
$761K Buy
+6,600
New +$723K ﹤0.01% 873
2017
Q4
Sell
-36,100
Closed -$2.78M 1053
2017
Q3
$2.78M Buy
+36,100
New +$2.76M 0.01% 631
2017
Q2
Sell
-800
Closed -$58K 981
2017
Q1
$58K Buy
+800
New +$55.3K ﹤0.01% 791
2016
Q2
Sell
-332,200
Closed -$19.2M 855
2016
Q1
$19.2M Buy
+332,200
New +$18.8M 0.15% 181
2015
Q1
Sell
-215,700
Closed -$12.1M 770
2014
Q4
$12.1M Buy
+215,700
New +$11.3M 0.08% 295

Other funds holding RMD

Point72 Asset Management's RMD Position: Q3 2023 in Review

Point72 Asset Management sold out of ResMed (RMD) in Q3 2023, closing a stake of 605,243 shares — an estimated $132M sold.

Point72 Asset Management first reported a position in RMD in Q4 2014 and held it in 16 quarters. The position peaked at $132M in Q2 2023. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • Point72 Asset Management reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
  • Point72 Asset Management sold 605,243 ResMed shares in Q3 2023, an estimated $132M.
  • Point72 Asset Management first reported a position in ResMed in Q4 2014 and held it in 16 quarters.
  • Point72 Asset Management's ResMed position peaked at $132M in Q2 2023.
  • 657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.